| Product Code: ETC9475929 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Pharmacogenetic Testing Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Sri Lanka Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sri Lanka Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing healthcare expenditure in Sri Lanka |
4.2.3 Rising prevalence of chronic diseases requiring personalized treatment |
4.3 Market Restraints |
4.3.1 Limited availability of skilled professionals for interpreting pharmacogenetic test results |
4.3.2 High cost associated with pharmacogenetic testing |
4.3.3 Lack of regulations and guidelines governing pharmacogenetic testing in Sri Lanka |
5 Sri Lanka Pharmacogenetic Testing Market Trends |
6 Sri Lanka Pharmacogenetic Testing Market, By Types |
6.1 Sri Lanka Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Sri Lanka Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Sri Lanka Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Sri Lanka Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Sri Lanka Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sri Lanka Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Sri Lanka Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Sri Lanka Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Sri Lanka Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Sri Lanka Pharmacogenetic Testing Market Export to Major Countries |
7.2 Sri Lanka Pharmacogenetic Testing Market Imports from Major Countries |
8 Sri Lanka Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services |
8.2 Adoption rate of pharmacogenetic testing by healthcare providers |
8.3 Patient satisfaction and outcomes improvement post pharmacogenetic testing |
9 Sri Lanka Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Sri Lanka Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sri Lanka Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Sri Lanka Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here